Searched for
DRUGMAKERS SHIPMENTS
Pharma exports to US seen muted this yearIndian pharma exports to the US face a subdued outlook this year. Policy uncertainties, falling generic prices, and regional conflicts are ...- European shares muted as rising autos, banks counter declining healthcare stocksAutomobiles gained 0.9%, with Milan-listed shares of Stellantis up 1.5% after the automaker said its global vehicle shipments rose 13% year...
- Pharma lobby flags 'cumbersome' export rule, seeks changePharma lobby groups are urging for changes to the centralized no-objection certification (NOC) for drug exports due to a significant export...
- Cipla in talks to add new customers for its China factory, executive saysIndian pharmaceutical giant Cipla is exploring at least two new overseas markets for products made at its Chinese manufacturing plant, as i...
- Nikkei index jumps as chip stocks rally ahead of Sino-US talksJapan's Nikkei share average advanced on Monday ahead of trade talks between the U.S. and China in London later in the day, with investors ...
- Pharma companies expected to absorb any tariff hit in short termU.S. tariffs on pharmaceuticals are unlikely to immediately raise brand-name drug prices, as drugmakers are expected to absorb initial cost...
- Trump tariff threats prompt some drugmakers to expedite shipments to USFearing potential tariffs from President Trump's announcement, some European drugmakers are increasing air shipments of medications to the ...
- Dr Reddy's, Cipla, Sun Pharma & others to see FY25 revenue boost in key US market, says India Ratings and ResearchIndian drugmakers, such as Dr Reddy's, Cipla, and Sun Pharma, are projected to maintain revenue growth in fiscal 2025, driven by drug short...
- Cipla expects record 24 per cent Ebitda margin in FY24"We enter reverse seasonalist in our India business. The fourth quarter has always been the lowest, so that impacts our margins," Umang Voh...
- Novavax says COVID vaccine triggers immune response to Omicron variantNovavax's two-dose, protein-based vaccine was authorized for use this week by European Union regulators and the World Health Organization.
- Dr. Reddy's eyes Sputnik vaccine exports after domestic struggleLast month India resumed exports of COVID-19 vaccines for the first time since it banned shipments in April in a bid to focus on inoculatin...
- South Korea approves Moderna's COVID-19 vaccineThe green light comes after two of three expert panels recommended approval be granted for the two-dose vaccine based on safety and efficac...
- Bayer aims to help CureVac with COVID-19 vaccine output, says CEOThough inoculation campaigns have started around the world using various COVID-19 vaccines, many countries say their ability to get shots i...
- Qatar, Oman to receive Pfizer-BioNTech COVID-19 vaccine this weekA ministry statement said people aged 16 years and above would be eligible. Qatar has also signed an agreement with drugmaker Moderna Inc t...
- Roche gets US nod for Covid-19 antibody testHospitals and reference laboratories can run the Elecsys Anti-SARS-CoV-2 test on one of Roche’s analysis platforms, the company said. Roche...
- Divi's Labs cracks 6% after disappointing Q1 numbersThe pharma major had posted a net profit of Rs 301.81 crore in the corresponding quarter of last year.
- Dr Reddy's acquires Habitrol brandDr Reddy's Laboratories has acquired Habitrol brand, a nicotine replacement therapy transdermal patch, from Novartis Consumer Health Inc.
- Ranbaxy recovers from fall; suspends shipments from two plantsReacting to the news, shares of the drug maker plunged as much as 2.3 per cent in trade on the BSE, but recouped early morning losses quick...
- Aurobindo, Glenmark, Natco get USFDA nod for migraine tabletsNatco said the drug shipments were already made and the product is being marketed by its partner Breckenridge Pharmaceuticals in the US mar...
- Govt to monitor drug exports using new techThe government plans to track each medicine exported out of the country using new technologies to prevent drugs from being duplicated.
Load More
